Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma

Sci Prog. 2024 Jan-Mar;107(1):368504241237888. doi: 10.1177/00368504241237888.

Abstract

Objectives: Research progress of human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) based on immune microenvironment.

Methods: This article preliminarily discusses the composition of immune microenvironment components and immune therapy and elaborates and analyzes the involvement and impact of T cells, B cells, natural killer (NK) cells, tumor-associated fibroblasts, and bone marrow-derived suppressor cells in HPV-positive HNSCC on tumor progression and prognosis. Furthermore, the application of immune-related therapies in HPV-positive HNSCC is explored.

Results: It is found that immune microenvironment research plays an important role in the pathogenesis and treatment of HPV-positive HNSCC.

Conclusions: Immune microenvironment research as an important means to explore tumors has played an important role in the study of HPV-positive HNSCC. We describe the biological significance of important components of HNSCC immune microenvironment by analyzing the effects of HNSCC immune microenvironment components and immunotherapy on HPV-positive HNSCC. May to provide new strategies for experimental research and clinical prevention and treatment of this disease.

Keywords: HPV-positive; head and neck; immune therapy; squamous cell carcinoma; tumor microenvironment.

Publication types

  • Review

MeSH terms

  • Carcinoma, Squamous Cell* / therapy
  • Head and Neck Neoplasms* / therapy
  • Human Papillomavirus Viruses
  • Humans
  • Papillomavirus Infections* / complications
  • Squamous Cell Carcinoma of Head and Neck / therapy
  • Tumor Microenvironment